The Florida Office of Insurance Regulation issued a consent order, requiring Humana to continue “procedures to ensure that it does not treat those living with HIV/AIDS less favorably than any other condition,” according to the report.
In 2014, the National Health Law Program and the AIDS Institute filed a complaint against the insurer, claiming it attempted to prevent AIDS patients from purchasing its plans by charging them higher copays for specific drugs.
According to Carl Schmid, deputy executive director of the AIDS Institute, Humana was charging copays of $1,000 per month, while other insurers — like Blue Cross and Blue Shield — were charging between $10 and $100 per month.
Humana spokesman Tom Noland said the insurer and the Florida Office of Insurance Regulation reached a consensus more than one year ago, agreeing “that there were no findings against Humana regarding discriminatory formulary practices,” according to the report. The insurer denied the claims in the OIR’s consent order.
More articles on payer issues:
Highmark isn’t the top insurer in Western Pa. anymore, UPMC analysis says
Moody’s: Health insurer mega-mergers to disrupt entire sector
CMS proposes hike in Medicare Advantage payments: 7 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
